Facts
The United Kingdom Anti-Doping (UKAD) had charged James Lockwood, the athlete, for a violation of the Anti-Doping Rules. On November 19, 2014, UKAD collected an out-of-competition sample from the Athlete for doping test purposes. His sample didn't show any prohibited substances, however the UKAD instructed the Laboratory to conduct a test for growth hormone releasing factors. The laboratory detected growth hormone releasing peptide-2 (pralmorelin) (‘GHRP-2’) and its metabolite which resulted in a positive test analysis on the A sample. GHRP-2 is a prohibited substance according the World Anti-Doping Agency (WADA) 2014 prohibited list.
History
The Athlete admitted the charge and waived his right to have the B
Sample analysed. The Athlete has been subject to a provisional suspension since the date of the charge.
Decision
The period of Ineligibility of two (2) years is imposed.
The period of Ineligibility commenced from March 3,2015 and will end at midnight on March 2, 2017.
